Abstract
INTRODUCTION Platelet tests measure the functional capacity of platelets to adhere, activate, aggregate, and secrete. The goal of platelet function testing is to provide information about the platelet contributions to the risk of thrombotic or hemorrhagic events. Important clinical questions in acute coronary syndromes are whether an antiplatelet agent is having the desired effect on platelet inhibition (efficacy) and whether the patient has sufficient residual platelet function to avoid bleeding (safety). While the role of aspirin and thienopyridines is well established in management of coronary artery disease and in the setting of coronary interventions continued refinement in dosing and patient response continues. Likewise, the last decade has demonstrated the unequivocal efficacy of intravenously administered platelet glycoprotein (GP) IIb/IIIa antagonists in the management of acute coronary syndromes and in the setting of percutaneous interventions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
